Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.
about
Novel drugs that target the metabolic reprogramming in renal cell cancerInhibition of chondrosarcoma growth by mTOR inhibitor in an in vivo syngeneic rat modelKinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients.GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.Synergistic roles of p53 and HIF1α in human renal cell carcinoma-cell apoptosis responding to the inhibition of mTOR and MDM2 signaling pathways.Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.Perifosine in renal cell carcinoma.Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.Notch 1 is a valuable therapeutic target against cell survival and proliferation in clear cell renal cell carcinoma.
P2860
Q26740187-81E7D22D-BA13-4DAC-9864-9AC3A536AE06Q34325616-DDC0C74F-11FE-4E66-AE06-43691F15488BQ35883559-41154003-61C4-4810-9F02-727C628A69B0Q36069860-152CF93B-1D14-4191-82C4-5C4DFFB78016Q36604270-D1A41675-9037-4C48-A49D-9F2309367BBAQ37602657-43E90144-8AB5-46A1-B06D-54101412D5C1Q38068572-45BFF1BF-24A4-4D45-A0CA-280B33E81C73Q39255433-A216F64C-1B83-4FAE-BA8A-D45484B8E0BAQ41621168-E28B4395-7971-4A17-A595-AFAA6CC7D9F9
P2860
Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluating rational non-cross- ...... TOR and AKT inhibitor therapy.
@ast
Evaluating rational non-cross- ...... TOR and AKT inhibitor therapy.
@en
type
label
Evaluating rational non-cross- ...... TOR and AKT inhibitor therapy.
@ast
Evaluating rational non-cross- ...... TOR and AKT inhibitor therapy.
@en
prefLabel
Evaluating rational non-cross- ...... TOR and AKT inhibitor therapy.
@ast
Evaluating rational non-cross- ...... TOR and AKT inhibitor therapy.
@en
P2093
P2860
P1476
Evaluating rational non-cross- ...... TOR and AKT inhibitor therapy.
@en
P2093
Clifford G Tepper
Danielle C Chinn
Jose E Pietri
Philip C Mack
Primo N Lara
William S Holland
P2860
P2888
P304
P356
10.1007/S00280-011-1684-Y
P577
2011-06-05T00:00:00Z
P6179
1039889374